This brand name is authorized in France, Netherlands
The drug RECIVIT contains one active pharmaceutical ingredient (API):
|
1
Fentanyl
UNII MUN5LYG46H - FENTANYL CITRATE
|
|
Fentanyl is a potent µ-opioid analgesic with rapid onset of analgesia and short duration of action. Its primary therapeutic actions are analgesia and sedation and is approximately 100-fold more potent than morphine as an analgesic. Secondary effects of fentanyl on central nervous system (CNS), respiratory and gastro-intestinal function are typical of opioid analgesics and are considered to be class effects. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| N02AB03 | Fentanyl | N Nervous system → N02 Analgesics → N02A Opioids → N02AB Phenylpiperidine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: FR | Base de données publique des médicaments | Identifier(s): 60774438, 61638238, 62287354, 64426863, 67634830 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 112925, 112933, 98205 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
